Cancer Clinical Trials: The Basics



Similar documents
Cancer Clinical Trials: In-Depth Information

National Cancer Institute

TAKING PART IN CANCER TREATMENT RESEARCH STUDIES

Clinical Trials: Questions and Answers

Ask Us About Clinical Trials

What Cancer Patients Need To Know

The NCI/VA Agreement on Clinical Trials: Questions and Answers. Key Points

LUNG CANCER CLINICAL TRIALS

Cancer Clinical Trials

Clinical Trials: Improving the Care of People Living With Cancer

Entering a Clinical Trial

Clinical Trials: The Crux of Cancer Innovation

Clinical Trial Design. Sponsored by Center for Cancer Research National Cancer Institute

A guide for the patient

Cancer Clinical Trials

Josephine Silvestre, RN, MSN The University of Chicago Medical Center. October 13, 2007

Participating in Alzheimer s Disease Clinical Trials and Studies

IF AT FIRST YOU DON T SUCCEED: TRIAL, TRIAL AGAIN

Patient Handbook on Stem Cell Therapies

The Clinical Trials Process an educated patient s guide

Clinical Trials: What You Need to Know

What are Clinical Trials?

Mesothelioma. Information for Patients and Families. identifying and evaluating experimental

CORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM

Clinical Trials and Screening: What You Need to Know

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health

A Guide to Clinical Trials

Clinical Trial Protocol Development. Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group

National Emphysema Treatment Trial (NETT) Consent for Screening and Patient Registry

Going to War. Lesson Summary: Student Learning Objectives: Standards: Materials:

A Greater Understanding. A Practical Guide to Clinical Trials

Medicals c i e n t i f i c study

Clinical Trials. Clinical trials the basics

Development and Implementation of the Reimbursement Strategy. Patty Curoe Telgener, RN, MBA VP of Reimbursement Services Emerson Consultants, Inc.

Glossary of Clinical Trial Terms

Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure

Frequently Asked Questions (FAQs)

Navigating GIST. The Life Raft Group June 12, 2008

Clinical Trials Network

How Is OnabotulinumtoxinA Reimbursed For Chronic Migraine? Impact Of FDA Approval And The New CPT Code

Understanding Clinical Trials for Blood Cancers. Blood Cancer Treatment Series

Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA Phone:

If you are signing for a minor child, you refers to your child throughout the consent document.

Clinical Trials Need More Subjects

Utah Advance Directive Form & Instructions

What is a clinical trial? An introduction for patients and families

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD

Guidelines for Cancer Prevention, Early detection & Screening. Prostate Cancer

Understanding Clinical Trial Recruitment Rules

Medical Billing Human Research Studies Seminar Notes

WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI Ethical Principles for Medical Research Involving Human Subjects

Advancing research: a physician s guide to clinical trials

BRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet

Medicare Billing. Lisa R. Pitler, JD, MS, RN Assistant Vice Chancellor Research, Director of Clinical Trials Office University of Illinois at Chicago

Summary and general discussion

Research on Research: Learning about Phase 1 Trials

Yale Cancer Center Data and Safety Monitoring Committee Charter

Neal Rouzier responds to the JAMA article on Men and Testosterone

1. General Information About The Mitochondrial Disease Biobank

Clinical Trials: What You Need to Know

Not All Clinical Trials Are Created Equal Understanding the Different Phases

Top Ten Things to Know About Stem Cell Treatments

Regulatory Pathways for Licensure and Use of Ebola Virus Vaccines During the Current Outbreak FDA Perspective

informed consent process

Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute

[Informed Consent Form for ] Name the group of individuals for whom this consent is written. Explanation Example

THE FUTURE OF CLINICAL TRIALS: NEW MODEL TO ENHANCE EFFICIENCY. Jeff Allen, PhD Executive Director Friends of Cancer Research

RESEARCH SUBJECT INFORMATION AND CONSENT FORM

UC DAVIS OFFICE OF RESEARCH AAHRPP Preparation UC Davis Human Research Part IV Criteria for Review. Cindy Gates IRB Administration

Understanding the Clinical Research Process and Principles of Clinical Research

This is meant to be a narrative rather than a critical summary I have a lot of questions about the proposal but I will look into these separately.

Kentucky Lung Cancer Research Program Strategic Plan Update

Clinical research trials and insurance

Thinking About Complementary & Alternative Medicine

Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia EXECUTIVE SUMMARY. New England Healthcare Institute

I was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several

Institutional Review Board

Transcription:

Cancer Clinical Trials: The Basics

What Are Cancer Clinical Trials? Research studies involving people Try to answer scientific questions and find better ways to prevent, diagnose, or treat cancer 2

Why Are Cancer Clinical Trials Important? Cancer affects all of us Each year in the U.S.A: More than half a million people are expected to die of cancer more than 1,500 people a day 1 of 4 deaths is from cancer More than 1 million new cancer cases are expected to be diagnosed 3

Why Are Cancer Clinical Trials Important? Clinical trials translate results of basic scientific research into better ways to prevent, diagnose, or treat cancer The more people that take part, the faster we can: Answer critical research questions Find better treatments and ways to prevent cancer 4

Do Many People Participate in Cancer Clinical Trials? Only 3 percent of U.S. adults with cancer participate in clinical trials 5

Types of Cancer Clinical Trials Treatment trials Prevention trials Early-detection trials/screening trials Diagnostic trials Quality-of-life studies/supportive care studies 6

Clinical Trial Phases Phase 1 trials How does the agent affect the human body? What dosage is safe? 7

Clinical Trial Phases Phase 2 trials Does the agent or intervention have an effect on the cancer? 8

Clinical Trial Phases Phase 3 trials Is the new agent or intervention (or new use of a treatment) better than the standard? Participants have an equal chance to be assigned to one of two or more groups 9

Randomized Trials Participants have an equal chance to be assigned to one of two or more groups: One gets the most widely accepted treatment (standard treatment) The other gets the new treatment being tested, which researchers hope and have reason to believe will be better than standard treatment 10

Randomization 11

Why Is Randomization Important? So all groups are as alike as possible Provides the best way to prove the effectiveness of a new agent or intervention 12

Cancer Treatment Trials What new treatments can help people who have cancer? What is the most effective treatment for people who have cancer? 13

Cancer Treatment Trials Placebos are almost never used: Placebos are used only when no standard treatment exists Patients are told of this possibility before deciding to take part 14

Cancer Prevention Trials Evaluate the effectiveness of ways to reduce the risk of cancer Enroll healthy people at high risk for developing cancer 15

Cancer Prevention Trials Action studies ( doing something ) Agent studies ( taking something ) also called chemoprevention studies 16

Chemoprevention Trials Phase 3 chemoprevention trials compare a promising new agent with either a: Standard agent Placebo 17

Clinical Trial Protocol A recipe or blueprint Strict scientific guidelines: Purpose of study How many people will participate Who is eligible to participate How the study will be carried out What information will be gathered about participants Endpoints 18

Benefits of Participation Possible benefits: Patients will receive, at a minimum, the best standard treatment If the new treatment or intervention is proven to work, patients may be among the first to benefit Patients have a chance to help others and improve cancer care 19

Risks of Participation Possible risks: New treatments or interventions under study are not always better than, or even as good as, standard care Even if a new treatment has benefits, it may not work for every patient Health insurance and managed care providers do not always cover clinical trials 20

Patient Protection There have, unfortunately, been past abuses in patient protection Federal regulations ensure that people are told about the benefits, risks, and purpose of research before they agree to participate 21

How Are Patients Rights Protected? Informed consent Scientific review Institutional review boards (IRBs) Data safety and monitoring boards 22

How Are Patients Rights Informed consent: Purpose Procedures Risks and potential benefits Individual rights Protected? 23

How Are Patients Rights Scientific review Protected? Institutional review boards (IRBs) are required by Federal law for trials that are: Federally funded Subject to FDA regulation 24

How Are Patients Rights Protected? Data and safety monitoring boards: Ensure that risks are minimized Ensure data integrity Stop a trial if safety concerns arise or objectives have been met 25

Why Do So Few Cancer Patients Participate in Clinical Trials? Sometimes patients: Don t know about clinical trials Don t have access to trials May be afraid or suspicious of research Can t afford to participate May not want to go against physician s wishes 26

Why Do So Few Cancer Patients Participate in Clinical Trials? Doctors might: Lack awareness of appropriate clinical trials Be unwilling to lose control of a person s care Believe that standard therapy is best Be concerned that clinical trials add administrative burdens 27

NCI Information Resources NCI Web site www.cancer.gov Cancer Information Service 1-800-4-CANCER TTY- 1-800-332-8615 www.cancer.gov/cis 28